You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 18, October 13, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Renal Diseases, Other
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

COMMENTS AND OPINIONS
Vitamin D Treatment in Chronic Kidney Disease: What We Really Need to Know

Pierre Delanaye, MD; Jean-Marie Krzesinski, MD, PhD; Etienne Cavalier, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with great interest the article by Kovesdy et al1 about the association between activated vitamin D (calcitriol) treatment and mortality in chronic kidney disease (CKD). The results are certainly of interest, but as the study is purely observational, these data must be confirmed on prospective randomized studies. At the end of the article, the authors are calling for such randomized studies comparing activated vitamin D and analogues. We have another proposal and working hypothesis that would involve a study comparing active vitamin D (1,25-dihydroxyvitamin D3 [1,25{OH}2-D3]) with native vitamin D (25-hydroxyvitamin D [25{OH}D]). Indeed, 25(OH)D can bind and directly activate vitamin D receptor. Even if 25(OH)D is 200 to 400 times less active than activated vitamin D, many studies suggest important physiological roles for native vitamin D, even in patient’s receiving hemodialysis.2 On one hand, circulating 25(OH)D plasma . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
Csaba P. Kovesdy, Shahram Ahmadzadeh, John E. Anderson, and Kamyar Kalantar-Zadeh
Arch Intern Med. 2008;168(4):397-403.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Vitamin D Therapy and Reduced Mortality in Chronic Kidney Disease
Hari Kumar K. V. S., Kirtikumar D. Modi, and Ratan Jha
Arch Intern Med. 2008;168(18):2045-2046.
EXTRACT | FULL TEXT  

Vitamin D Therapy and Reduced Mortality in Chronic Kidney Disease—Reply
Csaba Kovesdy, Shahram Ahmadzadeh, John Anderson, and Kamyar Kalantar-Zadeh
Arch Intern Med. 2008;168(18):2046.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.